Anthem Biosciences Ltd. (ANTHEM) closed at ₹936.80 on 19 Nov 2026, up 2.46 % on the day. Over the past year it is up 36.5 %; it stands 5.3 % below its 52-week high; it trades above its 200-day average. Its P/E is 85.9 on the last four quarters' profit. In Q2 FY27 (Jul-Sep 2026), profit grew 21.9 % and revenue grew 8.0 % from a year earlier, as the company reported. It is part of the NIFTY 500, in the Healthcare sector.
Overview Technical Risk & rank Results Accounts Filings Guidance & governance
The line uses prices adjusted for splits, bonuses and similar events.
Results in short
Q2 FY27 (Jul-Sep 2026), as the company reported it.
Anthem Biosciences Ltd. is part of the NIFTY 500. Figures are consolidated, from the company's results filed with NSE. Quality checks and outlook cover NIFTY 50 companies only, for now.